• Dry Cracked Skin
  • General Dermatology
  • Impetigo
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Latest News

Experts Review Key Factors in Alopecia Areata Severity and Morbidity Index, Treatment Decisions
Experts Review Key Factors in Alopecia Areata Severity and Morbidity Index, Treatment Decisions

March 4th 2024

Factors including disease duration, treatment response, and mental health were listed as crucial factors in severity and treatment.

QUIZ: AAD Atopic Dermatitis Guidelines
QUIZ: AAD Atopic Dermatitis Guidelines

March 4th 2024

Hypochlorous Acid: Is It Just a Trend? 
Hypochlorous Acid: Is It Just a Trend? 

March 4th 2024

POLL: Are You Attending the American Academy of Dermatology Annual Meeting?
POLL: Are You Attending the American Academy of Dermatology Annual Meeting?

March 4th 2024

The Cutaneous Connection: Decoding Atopic Dermatitis at AAD
The Cutaneous Connection: Decoding Atopic Dermatitis at AAD

March 4th 2024

Assessing the Relationship Between Psoriasis and Psoriatic Arthritis
Explore Vitiligo Management
Catch Up on What You Missed with Our Live Conference Coverage!
Systemic Therapies for Moderate-to-Severe AD

Conference Coverage

View All
POLL: Are You Attending the American Academy of Dermatology Annual Meeting?
POLL: Are You Attending the American Academy of Dermatology Annual Meeting?

March 4th 2024

Dermatology Conferences and Meetings Calendar 2024: March
Dermatology Conferences and Meetings Calendar 2024: March

March 1st 2024

Rilzabrutinib Rapidly Reduces Itch Severity in Adults with Chronic Spontaneous Urticaria
Rilzabrutinib Rapidly Reduces Itch Severity in Adults with Chronic Spontaneous Urticaria

February 26th 2024

La Roche-Posay Unveils New Molecule in Mela B3 Serum to Target Discoloration
La Roche-Posay Unveils New Molecule in Mela B3 Serum to Target Discoloration

February 23rd 2024

Latest Videos

All News

© 2024 MJH Life Sciences

All rights reserved.